Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression

Psychoneuroendocrinology

Volumn 33, Issue 2, 2008, Pages 152-161

  Owashi, Toshimi ^a,b   Otsubo, Tempei ^a   Oshima, Akihiko ^c   Nakagome, Kazuyuki ^d   Higuchi, Teruhiko ^e   Kamijima, Kunitoshi ^a,f  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d TOTTORI UNIVERSITY   (Japan)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^f INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Dexamethasone corticotropin releasing hormone (DEX CRH) test; Growth hormone releasing hormone (GHRH) test; Hypothalamic pituitary adrenocortical (HPA) system; Hypothalamic pituitary somatotropic (HPS) system; Psychotic depression

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; GROWTH HORMONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSIVE PSYCHOSIS; DISEASE SEVERITY; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL;

ADRENOCORTICOTROPIC HORMONE; ADULT; AGE FACTORS; AGED; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; AREA UNDER CURVE; CASE-CONTROL STUDIES; CORTICOTROPIN-RELEASING HORMONE; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; DEXAMETHASONE; FEMALE; FOLLOW-UP STUDIES; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; PSYCHOTIC DISORDERS; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SOMATOTROPHS; STATISTICS, NONPARAMETRIC; STIMULATION, CHEMICAL;

EID: 38349140075     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2007.10.011     Document Type: Article

References (60)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition, text revision (2000), American Psychiatric Association, Washington, DC
2. Appelhof B.C., Huyser J., Verweij M., Brouwer J.P., van Dyck R., Fliers E., Hoogendijk W.J., Tijssen J.G., Wiersinga W.M., and Schene A.H. Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression). Biol. Psychiatry 59 (2006) 696-701
3. Birmaher B., Dahl R.E., Williamson D.E., Perel J.M., Brent D.A., Axelson D.A., Kaufman J., Dorn L.D., Stull S., Rao U., and Ryan N.D. Growth hormone secretion in children and adolescents at high risk for major depressive disorder. Arch. Gen. Psychiatry 57 (2000) 867-872
4. Contreras F., Navarro M.A., Menchon J.M., Rosel P., Serrallonga J., Perez-Arnau F., Urretavizcaya M., and Vallejo J. Growth hormone response to growth hormone releasing hormone in non-delusional and delusional depression and healthy controls. Psychol. Med. 26 (1996) 301-307
5. Contreras F., Menchon J.M., Urretavizcaya M., Navarro M.A., Vallejo J., and Parker G. Hormonal differences between psychotic and non-psychotic melancholic depression. J. Affect. Disord. 100 (2007) 65-73
6. Coote M., Wilkins A., Werstiuk E.S., and Steiner M. Effects of electroconvulsive therapy and desipramine on neuroendocrine responses to the clonidine challenge test. J. Psychiatry Neurosci. 23 (1998) 172-178
7. Correa H., Duval F., Claude M.M., Bailey P., Tremeau F., Diep T.S., Crocq M.A., Castro J.O., and Macher J.P. Noradrenergic dysfunction and antidepressant treatment response. Eur. Neuropsychopharmacol. 11 (2001) 163-168
8. Coryell W., Lavori P., Endicott J., Keller M., and VanEerdewegh M. Outcome in schizoaffective, psychotic, and nonpsychotic depression. Course during a six- to 24-month follow-up. Arch. Gen. Psychiatry 41 (1984) 787-791
9. Crespi F., Paret J., Keane P.E., Morre M., Coude F.X., and Roncucci R. Growth hormone-releasing factor modifies dopaminergic but not serotonergic activity in the arcuate nucleus of hypothalamus in the rat, as recorded in vivo by differential pulse voltammetry. Brain Res. 348 (1985) 367-370
10. Dahl R.E., Birmaher B., Williamson D.E., Dorn L., Perel J., Kaufman J., Brent D.A., Axelson D.A., and Ryan N.D. Low growth hormone response to growth hormone-releasing hormone in child depression. Biol. Psychiatry 48 (2000) 981-988
11. Dainippon Sumitomo Pharma Co., Ltd. GRF Sumitomo Package Insert. 〈http://www.info.pmda.go.jp/go/pack/7223405D1028_2_01/〉.
12. Duval F., Mokrani M.C., Crocq M.A., Bailey P.E., Diep T.S., Correa H., and Macher J.P. Dopaminergic function and the cortisol response to dexamethasone in psychotic depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 24 (2000) 207-225
13. Eriksson E., Balldin J., Lindstedt G., and Modigh K. Growth hormone responses to the alpha 2-adrenoceptor agonist guanfacine and to growth hormone releasing hormone in depressed patients and controls. Psychiatry Res. 26 (1988) 59-67
14. Flint A.J., and Rifat S.L. Two-year outcome of psychotic depression in late life. Am. J. Psychiatry 155 (1998) 178-183
15. Frieboes R.M., Sonntag A., Yassouridis A., Eap C.B., Baumann P., and Steiger A. Clinical outcome after trimipramine in patients with delusional depression-a pilot study. Pharmacopsychiatry 36 (2003) 12-17
16. Goldberg J.F., and Harrow M. Consistency of remission and outcome in bipolar and unipolar mood disorders: a 10-year prospective follow-up. J. Affect. Disord. 81 (2004) 123-131
17. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 6 (1967) 278-296
18. Hatzinger M., Hemmeter U.M., Baumann K., Brand S., and Holsboer-Trachsler E. The combined DEX-CRH test in treatment course and long-term outcome of major depression. J. Psychiatr. Res. 36 (2002) 287-297
19. Heuser I., Yassouridis A., and Holsboer F. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J. Psychiatr. Res. 28 (1994) 341-356
20. Heuser I.J., Gotthardt U., Schweiger U., Schmider J., Lammers C.H., Dettling M., and Holsboer F. Age-associated changes of pituitary-adrenocortical hormone regulation in humans: importance of gender. Neurobiol. Aging 15 (1994) 227-231
21. Heuser I.J., Schweiger U., Gotthardt U., Schmider J., Lammers C.H., Dettling M., Yassouridis A., and Holsboer F. Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. Am. J. Psychiatry 153 (1996) 93-99
22. Hollingshead A.B. Four Factor Index of Social Status (1975), Department of Sociology, Yale University, New Haven, CT
23. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23 (2000) 477-501
24. Holsboer F., von Bardeleben U., Wiedemann K., Muller O.A., and Stalla G.K. Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression. Biol. Psychiatry 22 (1987) 228-234
25. Holsboer-Trachsler E. Repeated administration of the combined dexamethasone human corticotropin releasing hormone stimulation test during treatment of depression. Psychiatry Res. 38 (1991) 163-171
26. Ising M., Kunzel H.E., Binder E.B., Nickel T., Modell S., and Holsboer F. The combined dexamethasone/CRH test as a potential surrogate marker in depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 29 (2005) 1085-1093
27. Ising M., Horstmann S., Kloiber S., Lucae S., Binder E.B., Kern N., Kunzel H.E., Pfennig A., Uhr M., and Holsboer F. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression-a potential biomarker?. Biol. Psychiatry 62 (2007) 47-54
28. Isogawa K., Nagayama H., Tsutsumi T., Kiyota A., Akiyoshi J., and Hieda K. Simultaneous use of thyrotropin-releasing hormone test and combined dexamethasone/corticotropine-releasing hormone test for severity evaluation and outcome prediction in patients with major depressive disorder. J. Psychiatr. Res. 39 (2005) 467-473
29. Jarrett D.B., Miewald J.M., and Kupfer D.J. Recurrent depression is associated with a persistent reduction in sleep-related growth hormone secretion. Arch. Gen. Psychiatry 47 (1990) 113-118
30. Johnson J., Horwath E., and Weissman M.M. The validity of major depression with psychotic features based on a community study. Arch. Gen. Psychiatry 48 (1991) 1075-1081
31. Keller J., Flores B., Gomez R.G., Solvason H.B., Kenna H., Williams G.H., and Schatzberg A.F. Cortisol circadian rhythm alterations in psychotic major depression. Biol. Psychiatry 60 (2006) 275-281
32. Krishnan K.R.R., Davidson J.R.T., Rayasam K., Tanas K.S., Shope F.S., and Pelton S. Diagnostic utility of the DST. Biol. Psychiatry 22 (1987) 618-628
33. Kunugi H., Ida I., Owashi T., Kimura M., Inoue Y., Nakagawa S., Yabana T., Urushibara T., Kanai R., Aihara M., Yuuki N., Otsubo T., Oshima A., Kudo K., Inoue T., Kitaichi Y., Shirakawa O., Isogawa K., Nagayama H., Kamijima K., Nanko S., Kanba S., Higuchi T., and Mikuni M. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study. Neuropsychopharmacology 31 (2006) 212-220
34. Kunzel H.E., Binder E.B., Nickel T., Ising M., Fuchs B., Majer M., Pfennig A., Ernst G., Kern N., Schmid D.A., Uhr M., Holsboer F., and Modell S. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the De over(x, ̃) CRH test. Neuropsychopharmacology 28 (2003) 2169-2178
35. Lal S. Apomorphine in the evaluation of dopaminergic function in man. Prog. Neuropsychopharmacol. Biol. Psychiatry 12 (1988) 117-164
36. Lesch K.P., Muller U., Rupprecht R., Kruse K., and Schulte H.M. Endocrine responses to growth hormone-releasing hormone, thyrotropin-releasing hormone and corticotropin-releasing hormone in depression. Acta Psychiatr. Scand. 79 (1989) 597-602
37. Lykouras E., Markianos M., Malliaras D., and Stefanis C. Neurochemical variables in delusional depression. Am. J. Psychiatry 145 (1988) 214-217
38. Meltzer H.Y., Kolakowska T., Fang V.S., Fogg L., Robertson A., Lewine R., Strahilevitz M., and Busch D. Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Relation to duration of illness and depressive symptoms. Arch. Gen. Psychiatry 41 (1984) 512-519
39. Nelson J.C., and Davis J.M. DST studies in psychotic depression: a meta-analysis. Am. J. Psychiatry 154 (1997) 1497-1503
40. Ohayon M.M., and Schatzberg F.A. Prevalence of depressive episodes with psychotic features in the general population. Am. J. Psychiatry 159 (2002) 1855-1861
41. Oshima A., Yamashita S., Owashi T., Murata T., Tadokoro C., Miyaoka H., Kamijima K., and Higuchi T. The differential ACTH responses to combined dexamethasone/CRH administration in major depressive and dysthymic disorders. J. Psychiatr. Res. 34 (2000) 325-328
42. Owashi, T., Otsubo, T., Oshima, A., Nakagome, K., Higuchi, T., Kamijima, K., in press. DEX/CRH and GHRH test results to the outcome of depression-preliminary results suggest the GHRH test may predict relapse after discharge. J. Psychiatr. Res. doi:10.1016/j.jpsychires.2007.01.006.
43. Peabody C.A., Warner M.D., Markoff E., Hoffman A.R., Wilson D.M., and Csernansky J.G. Growth hormone response to growth hormone releasing hormone in depression and schizophrenia. Psychiatry Res. 33 (1990) 269-276
44. Pintor L., Torres X., Navarro V., Martinez de Osaba M.A., Matrai S., and Gasto C. Corticotropin-releasing factor test in melancholic patients in depressed state versus recovery: a comparative study. Prog. Neuropsychopharmacol. Biol. Psychiatry 31 (2007) 1027-1033
45. Pitchot W., Hansenne M., Moreno A.G., von Frenckell R., and Ansseau M. Psychopathological correlates of dopaminergic disturbances in major depression. Neuropsychobiology 24 (1990-1991) 169-172
46. Pitchot W., Hansenne M., Moreno A.G., and Ansseau M. Suicidal behavior and growth hormone response to apomorphine test. Biol. Psychiatry 31 (1992) 1213-1219
47. Plotsky P.M., Owens M.J., and Nemeroff C.B. Psychoneuroendocrinology of depression: hypothalamic-pituitary-adrenal axis. Psychiatr. Clin. N. Am. 21 (1998) 293-307
48. Puig-Antich J., Novacenko H., Davies M., Tabrizi M.A., Ambrosini P., Goetz R., Bianca J., Goetz D., and Sachar E.J. Growth hormone secretion in prepubertal children with major depression. III. Response to insulin-induced hypoglycemia after recovery from a depressive episode and in a drug-free state. Arch. Gen. Psychiatry 41 (1984) 471-475
49. Rybakowski J.K., and Twardowska K. The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness. J. Psychiatr. Res. 33 (1999) 363-370
50. Schatzberg A.F., Rothschild A.J., Langlais P.J., Bird E.D., and Cole J.O. A corticosteroid/dopamine hypothesis for psychotic depression and related states. J. Psychiatr. Res. 19 (1985) 57-64
51. Schoevers R.A., Geerlings M.I., Beekman A.T., Penninx B.W., Deeg D.J., Jonker C., and Van Tilburg W. Association of depression and gender with mortality in old age. Results from the Amsterdam Study of the Elderly (AMSTEL). Br. J. Psychiatry 177 (2000) 336-342
52. Thakur M., Hays J., Ranga K., and Krishnan R. Clinical, demographic and social characteristics of psychotic depression. Psychiatry Res. 86 (1999) 99-106
53. Vale W., Spiess J., Rivier C., and Rivier J. Characterization of a 41 residue ovine hypothalamic peptide that stimulates secretion of corticotrophin of b-endorphin. Science 213 (1981) 1394-1397
54. Vance M.L., Kaiser D.L., Frohman L.A., Rivier J., Vale W.W., and Thorner M.O. Role of dopamine in the regulation of growth hormone secretion: dopamine and bromocriptine augment growth hormone (GH)-releasing hormone-stimulated GH secretion in normal man. J. Clin. Endocrinol. Metab. 64 (1987) 1136-1141
55. Vythilingam M., Chen J., Bremner J.D., Mazure C.M., Maciejewski P.K., and Nelson J.C. Psychotic depression and mortality. Am. J. Psychiatry 160 (2003) 574-576
56. Watson S., Porter R.J., and Young A.H. Effect of hydrocortisone on the pituitary response to growth hormone releasing hormone. Psychopharmacology (Berlin) 152 (2000) 40-46
57. Watson S., Gallagher P., Ritchie J.C., Ferrier I.N., and Young A.H. Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. Br. J. Psychiatry 184 (2004) 496-502
58. Watson S., Gallagher P., Smith M.S., Ferrier I.N., and Young A.H. The dex/CRH test-is it better than the DST?. Psychoneuroendocrinology 31 (2006) 889-894
59. Young E.A., Abelson J.L., and Cameron O.G. Interaction of brain noradrenergic system and the hypothalamic-pituitary-adrenal (HPA) axis in man. Psychoneuroendocrinology 30 (2005) 807-814
60. Zobel A.W., Nickel T., Sonntag A., Uhr M., Holsboer F., and Ising M. Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. A prospective study. J. Psychiatr. Res. 35 (2001) 83-94